Cargando…

Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer

The epidermal growth factor receptor (EGFR) is commonly expressed in non-small-cell lung cancer (NSCLC) and promotes a host of mechanisms involved in tumorigenesis. However, EGFR expression does not reliably predict prognosis or response to EGFR-targeted therapies. The data from two previous studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swinson, D E B, Cox, G, O'Byrne, K J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409909/ https://www.ncbi.nlm.nih.gov/pubmed/15365565 http://dx.doi.org/10.1038/sj.bjc.6602149

Ejemplares similares

Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence
por: Hernes, E, et al.
Publicado: (2004)

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
por: Koukourakis, M I, et al.
Publicado: (2003)

A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma
por: Fontanini, G, et al.
Publicado: (2002)

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma
por: Abd El-Rehim, D M, et al.
Publicado: (2004)

Identification of epidermal growth factor receptor-derived peptides immunogenic for HLA-A2(+) cancer patients
por: Shomura, H, et al.
Publicado: (2004)

The tumour–stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients
por: Masuya, D, et al.
Publicado: (2004)

LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–PCR and immunohistochemical analysis
por: Thomasson, M, et al.
Publicado: (2003)

Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line
por: Banerjee, R, et al.
Publicado: (2004)

Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma
por: Pazgal, I, et al.
Publicado: (2002)

Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence
por: Gu, C, et al.
Publicado: (2004)

Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer
por: Takizawa, S, et al.
Publicado: (2003)

Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas
por: Ikematsu, S, et al.
Publicado: (2003)

Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer
por: Sardari Nia, P, et al.
Publicado: (2004)

Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis
por: Wang, W, et al.
Publicado: (2004)

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis
por: Yousef, G M, et al.
Publicado: (2002)

Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma
por: Yokoyama, Y, et al.
Publicado: (2003)

Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura
por: Edwards, J G, et al.
Publicado: (2003)

Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma
por: Shimada, H, et al.
Publicado: (2002)

Phosphorylated tyrosine-containing proteins in primary lung cancer correlates with proliferation and prognosis
por: Gong, Y, et al.
Publicado: (2002)

The effect of cigarette smoking use and cessation on serum insulin-like growth factors
por: Renehan, A G, et al.
Publicado: (2004)

Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1
por: Ebert, M P A, et al.
Publicado: (2002)

Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients
por: Osella-Abate, S, et al.
Publicado: (2003)

Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis
por: Li, C, et al.
Publicado: (2003)

Fibroblast growth factor 8 is expressed at higher levels in lactating human breast and in breast cancer
por: Zammit, C, et al.
Publicado: (2002)

Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis
por: Sedlaczek, N, et al.
Publicado: (2003)

Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen
por: Coradini, D, et al.
Publicado: (2003)

Nuclear survivin as a biomarker for non-small-cell lung cancer
por: Lu, B, et al.
Publicado: (2004)

Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas
por: Passalidou, E, et al.
Publicado: (2002)

Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients
por: Nakashima, T, et al.
Publicado: (2003)

A comparison of serum and plasma levels of vascular endothelial growth factor during the menstrual cycle in healthy female volunteers
por: McIlhenny, C, et al.
Publicado: (2002)

ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours
por: Vicent, S, et al.
Publicado: (2004)

N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers
por: Dosaka-Akita, H, et al.
Publicado: (2002)

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas
por: Hirsch, F R, et al.
Publicado: (2002)

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy
por: Manders, P, et al.
Publicado: (2002)

High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma
por: Hiyama, E, et al.
Publicado: (2004)

Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients
por: Bachelot, T, et al.
Publicado: (2003)

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
por: Forrest, L M, et al.
Publicado: (2003)

CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer
por: Hibi, K, et al.
Publicado: (2004)

S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas
por: Smith, S L, et al.
Publicado: (2004)

Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells
por: Junnikkala, S, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_ag3km3j0ij12s4v8i0mt3laj59